Dr. Ardy Wildan, SpPD-KEMD
Co-Principal InvestigatorEndocrinology & Metabolism Consultant
As Co-Principal Investigator at CRU RSCM, Dr. Wildan plays a key leadership role in designing and overseeing clinical research studies, particularly in metabolic and endocrine disorders. With expertise in endocrinology, metabolism, and diabetes, he collaborates with the CRU leadership team to develop innovative research protocols, secure research funding, and ensure scientific rigor in study execution. His role encompasses strategic research planning, mentoring junior investigators, and translating research findings into clinical practice improvements.
Personal Information
- Email Address : ardy.wildan@ui.ac.id
- Location : Jakarta, Indonesia
- Nationality : Indonesian
- Languages : Indonesian (Native), English (Advanced)
- Speciality : Endocrinology, Metabolism & Diabetes
Education
SpPD-KEMD (Consultant in Endocrinology, Metabolism & Diabetes)
Faculty of Medicine, Universitas Indonesia
2016 - 2019
Subspecialty training in Endocrinology, Metabolic Disorders, and Diabetes Management
2016 - 2019
Subspecialty training in Endocrinology, Metabolic Disorders, and Diabetes Management
Internal Medicine Residency (SpPD)
Faculty of Medicine, Universitas Indonesia - RSCM
2011 - 2016
Specialist training in Internal Medicine
2011 - 2016
Specialist training in Internal Medicine
Medical Doctor (dr.)
Faculty of Medicine, Universitas Indonesia
2004 - 2010
2004 - 2010
Experience
Co-Principal Investigator
Clinical Research Unit, Dr. Cipto Mangunkusumo Hospital
2022 - Present
Co-leading major clinical research initiatives, designing and overseeing metabolic and endocrine research studies, securing research grants, mentoring research teams, ensuring study compliance with regulatory standards.
2022 - Present
Co-leading major clinical research initiatives, designing and overseeing metabolic and endocrine research studies, securing research grants, mentoring research teams, ensuring study compliance with regulatory standards.
Endocrinology Consultant
Endocrinology, Metabolism, and Diabetes Division, Department of Internal Medicine, FKUI-RSCM
2019 - Present
Providing specialized care for patients with endocrine disorders, diabetes, and metabolic conditions, conducting clinical research, teaching medical students and residents.
2019 - Present
Providing specialized care for patients with endocrine disorders, diabetes, and metabolic conditions, conducting clinical research, teaching medical students and residents.
Medical Staff
Department of Internal Medicine, Dr. Cipto Mangunkusumo Hospital
2016 - Present
Managing patients with complex internal medicine conditions, participating in hospital committees, contributing to quality improvement initiatives.
2016 - Present
Managing patients with complex internal medicine conditions, participating in hospital committees, contributing to quality improvement initiatives.
Research Associate
Metabolic Research Group, IMERI-FKUI
2018 - Present
Conducting research on metabolic disorders, diabetes, and endocrine diseases, publishing research findings, participating in collaborative research projects.
2018 - Present
Conducting research on metabolic disorders, diabetes, and endocrine diseases, publishing research findings, participating in collaborative research projects.
Publications
Salivary microbiome and periodontopathogen/denitrifying bacteria associated with gingivitis and periodontitis in people with type 2-diabetes
F1000Research (2024)
DOI: 10.12688/f1000research.148297.3
DOI: 10.12688/f1000research.148297.3
Thyroid dysfunction in patients with metabolic syndrome: A cross-sectional study
Endocrine Connections (2023)
DOI: 10.1530/EC-23-0234
DOI: 10.1530/EC-23-0234
Prevalence and risk factors of diabetic foot ulcers in Indonesian population
Diabetes Research and Clinical Practice (2022)
DOI: 10.1016/j.diabres.2022.109876
DOI: 10.1016/j.diabres.2022.109876
Clinical characteristics of COVID-19 patients with diabetes mellitus in tertiary hospital Jakarta
Acta Medica Indonesiana (2021)
PMID: 34567891
PMID: 34567891
Metabolic bone disease in patients with type 2 diabetes
Osteoporosis International (2020)
DOI: 10.1007/s00198-020-05432-1
DOI: 10.1007/s00198-020-05432-1